NEWS - Genetic test for psoriatic arthritis now available in Europe

[Guest guest]

PsoriasisDX Genetic Test For Psoriatic Arthritis Now Available In

Europe As A CE Marked In Vitro Diagnostic Medical Device

MedicalNewsToday.com

Article Date: 22 Jul 2010 - 1:00 PDT

Molecular dermatology research and development innovator DermaGenoma,

Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic

Arthritis (PsA) is now available as a CE Marked product under the

European In Vitro Diagnostic Directive.

CE Marking is required for certain product groups to indicate

conformity with the essential requirements set out in European

Directives. The PsoriasisDX Genetic Test for Psoriatic Arthritis

complies with the essential requirements of the European IVD

Directive.

The PsoriasisDX Genetic Test helps identify those at high risk for

developing Psoriatic Arthritis before they experience arthritic

symptoms, providing the opportunity to lessen joint damage through

early medical intervention.

" We are excited to extend this revolutionary genetics testing

breakthrough to dermatologists in Europe, " says Andy Goren, CEO of

DermaGenoma, Inc. " It helps doctors determine the proper treatments

for patients. "

Source:

DermaGenoma, Inc.

http://www.medicalnewstoday.com/articles/195471.php

Not an MD